The need to define "who" rather than "if" for ECMO in COVID-19
Intensive Care Med
.
2022 Jul;48(7):979-980.
doi: 10.1007/s00134-022-06732-y.
Epub 2022 May 17.
Authors
Stephen Whebell
1
,
Joe Zhang
2
3
,
Rebecca Lewis
4
,
Michael Berry
5
,
Stephane Ledot
5
,
Andrew Retter
4
,
Luigi Camporota
4
6
Affiliations
1
Intensive Care Unit, Townsville University Hospital, Townsville, QLD, Australia.
[email protected]
.
2
Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
3
Institute of Global Health Innovation, Imperial College, London, UK.
4
Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.
5
Department of Adult Intensive Care, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
6
Division of Asthma, Allergy and Lung Biology, King's College, London, UK.
PMID:
35579687
PMCID:
PMC9112247
DOI:
10.1007/s00134-022-06732-y
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19* / therapy
Extracorporeal Membrane Oxygenation*
Humans
Respiratory Distress Syndrome* / therapy
SARS-CoV-2
Grants and funding
203928/Z/16/Z/WT_/Wellcome Trust/United Kingdom